PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-01-29

Date Title Company
29-Jan-2024 Pharma-Bio Serv Announces Full Year Results AccessWire
29-Jan-2024 FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates AccessWire
29-Jan-2024 Gedeon Richter becomes strategic investor of Formycon via equity investment Formycon AG
29-Jan-2024 Formycon resolves on cash capital increase of EUR 82.84 million – all new shares were subscribed by Gedeon Richter as new strategic investor Formycon AG
29-Jan-2024 America's Best Dentist is Now Serving Fountain Valley in Cosmetic Dentistry as KYT Dental Services AccessWire
29-Jan-2024 MeVis publishes figures for financial year 2022/2023 and forecast for 2023/2024 MeVis Medical Solutions AG
29-Jan-2024 Fitbit and Quest Diagnostics Collaborate To Advance Research on the Use of Wearable Devices To Improve Metabolic Health AccessWire
29-Jan-2024 LightWork Therapy & Recovery Expands Services With Evening Outpatient Programs for Women AccessWire
29-Jan-2024 Boom in life science recruitment leads to ARx expansion plans ARx
29-Jan-2024 Specialty-Driven Platforms Outperform Broad-Spectrum EHRs in Top 2024 Physician Satisfaction Ratings, 14th Annual Black Book Ambulatory Practice Surveys AccessWire
29-Jan-2024 Aurora Behavioral Health Announces Executive Leadership Promotions AccessWire
29-Jan-2024 The Wall Street Journal Names Merck Among Top 10 Best-Managed Companies AccessWire
29-Jan-2024 Jaguar Health to Present January 31 at The Microcap Conference and Participate in a Fireside Chat February 1 at the Lytham Partners Investor Select Conference AccessWire
29-Jan-2024 Tharimmune Announces Initiation of Phase 1 Clinical Trial of TH104 and Provides Business Update AccessWire
29-Jan-2024 Protagonist Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 2024 AccessWire
29-Jan-2024 Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st AccessWire
29-Jan-2024 PMD Announces New ISIN Code and Timetable for Reverse Split of Shares AccessWire
29-Jan-2024 Safety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Found AccessWire
29-Jan-2024 Aripiprazole once-every-two-months long-acting injectable recommended for approval in the EU by the CHMP for the maintenance treatment of schizophrenia in adult patients stabilised with aripiprazole Otsuka Pharmaceutical
29-Jan-2024 Update on Regulatory Review of leriglitazone in the EU Minoryx Therapeutics